Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Lai E, Astara G, Ziranu P, Pretta A, Migliari M, Dubois M, Donisi C, Mariani S, Liscia N, Impera V, Persano M, Tolu S, Balconi F, Pinna G, Spanu D, Pireddu A, Saba G, Camera S, Musio F, Puzzoni M, Pusceddu V, Madeddu C, Casadei Gardini A, Scartozzi M. Lai E, et al. Among authors: madeddu c. Crit Rev Oncol Hematol. 2021 Jan;157:103167. doi: 10.1016/j.critrevonc.2020.103167. Epub 2020 Nov 12. Crit Rev Oncol Hematol. 2021. PMID: 33271389 Review.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A. Mantovani G, et al. Among authors: madeddu c. Int J Oncol. 2002 Feb;20(2):419-27. Int J Oncol. 2002. PMID: 11788911 Clinical Trial.
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Mantovani G, Macciò A, Madeddu C, Mulas C, Massa E, Astara G, Ferreli L, Mudu MC, Gramignano G, Murgia V, Lusso MR, Mocci M, Cardia A, Mura L. Mantovani G, et al. Among authors: madeddu c. Oncol Rep. 2002 Jul-Aug;9(4):887-96. Oncol Rep. 2002. PMID: 12066227 Clinical Trial.
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Lusso MR, Camboni P, Ferreli L, Mocci M, Perboni S, Mura L, Madeddu C, Macciò A. Mantovani G, et al. Among authors: madeddu c. Oncol Rep. 2003 Jan-Feb;10(1):197-206. Oncol Rep. 2003. PMID: 12469169 Clinical Trial.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M. Mantovani G, et al. Among authors: madeddu c. Oncol Rep. 2003 May-Jun;10(3):759-66. Oncol Rep. 2003. PMID: 12684655 Clinical Trial.
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.
Mantovani G, Madeddu C, Gramignano G, Lusso MR, Mocci M, Massa E, Ferreli L, Astara G, Macciò A, Serpe R. Mantovani G, et al. Among authors: madeddu c. J Exp Ther Oncol. 2003 Jul-Aug;3(4):205-19. doi: 10.1046/j.1359-4117.2003.01096.x. J Exp Ther Oncol. 2003. PMID: 14567291 Clinical Trial.
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
Massa E, Madeddu C, Lusso MR, Gramignano G, Mantovani G. Massa E, et al. Among authors: madeddu c. Crit Rev Oncol Hematol. 2006 Feb;57(2):175-82. doi: 10.1016/j.critrevonc.2005.06.001. Epub 2005 Oct 6. Crit Rev Oncol Hematol. 2006. PMID: 16213740 Clinical Trial.
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
Mantovani G, Macciò A, Madeddu C, Gramignano G, Lusso MR, Serpe R, Massa E, Astara G, Deiana L. Mantovani G, et al. Among authors: madeddu c. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1030-4. doi: 10.1158/1055-9965.EPI-05-0538. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702388 Clinical Trial.
148 results